Oklahoma City-based Selexys Pharmaceuticals wins investment, strikes $665 million deal

Oklahoma City bioscience company’s early success in developing a drug to treat sickle cell anemia attracts attention of one of the largest pharmaceutical companies in the world.

BY DON MECOY Published: September 20, 2012
Advertisement
;

In what promises to be the biggest bioscience firm deal in state history, Oklahoma City-based Selexys Pharmaceuticals Corp. has struck an agreement that could lead to the company’s acquisition for up to $665 million.

“This is the...

Oklahoman subscribers have access to this article. Unlock it below.

What is this? Learn more.

NewsOK.com has disabled the comments for this article.